Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer
Clinical trial NCT01547260 · COMPLETED
Trial details
- NCT number
- NCT01547260
- Sponsor
- Maria Liljefors
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2014-01-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.